✨ #Kite annonce l’acquisition d’#Interius pour 350 millions $ se lançant ainsi dans la prochaine génération de #CAR_T 🧬 in vivo
Cette décision change la donne dans la course pour rendre les #CAR_Tcells 🧬 plus évolutives, accessibles et potentiellement curatives
#CellTherapy 🧬 #CellAndGeneTherapy 🧬
Cette décision change la donne dans la course pour rendre les #CAR_Tcells 🧬 plus évolutives, accessibles et potentiellement curatives
#CellTherapy 🧬 #CellAndGeneTherapy 🧬
August 30, 2025 at 5:01 AM
Everybody can reply
1 likes
“Skilled clinical staff are more in demand than ever—and cuts to NIH funding are driving costs even higher,” says Heather Purvis of Title21 in Clinical Trials Arena.
📰 Read the article here: www.clinicaltrialsarena.com/features/how...
#Biotech #CellAndGeneTherapy #NIHFunding #LifeSciences
📰 Read the article here: www.clinicaltrialsarena.com/features/how...
#Biotech #CellAndGeneTherapy #NIHFunding #LifeSciences
How can pharma manage rising trial costs?
With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage expenses.
www.clinicaltrialsarena.com
April 14, 2025 at 5:24 PM
Everybody can reply
#CellandGeneTherapy #CGT #Uniphar #personalisedmedicine #Celltherapy #CARTcelltherapy #Genetherapy #CGTlandscape #CGTpipeline #genetherapytrials #Expandedaccess #NamedPatientSupply #FreeofChargeaccess #FOCaccess #MAPs #EAPs #realworldevidencegeneration #marketreadiness
zurl.co/2pdyj
zurl.co/2pdyj
firstwordpharma.com
September 29, 2025 at 10:58 AM
Everybody can reply
☀️ VectorBuilder is at the #BMES2025 Annual Meeting, and we can’t wait to connect with the biomedical engineering community!
📍 Booth 224 | 📅 October 8-12
Stop by and say hello to our team!
#BMES2025 #VectorBuilder #BiomedicalEngineering #GeneTherapy #BiotechEvents #CellAndGeneTherapy
📍 Booth 224 | 📅 October 8-12
Stop by and say hello to our team!
#BMES2025 #VectorBuilder #BiomedicalEngineering #GeneTherapy #BiotechEvents #CellAndGeneTherapy
October 8, 2025 at 5:42 PM
Everybody can reply
2 likes
#BiotechInnovation
#ImmuneResponse
#LymphomaTreatment
#ClinicalTrials
#CellEngineering
#CytokineTherapy
#NextGenMedicine
#PersonalizedMedicine
#RegenerativeMedicine
#CellAndGeneTherapy
#TumorMicroenvironment
#CancerCare
#TCellActivation
#AntibodyTherapy
#ResearchForACure
#ImmuneResponse
#LymphomaTreatment
#ClinicalTrials
#CellEngineering
#CytokineTherapy
#NextGenMedicine
#PersonalizedMedicine
#RegenerativeMedicine
#CellAndGeneTherapy
#TumorMicroenvironment
#CancerCare
#TCellActivation
#AntibodyTherapy
#ResearchForACure
November 17, 2024 at 12:38 AM
Everybody can reply
March 29, 2025 at 2:43 AM
Everybody can reply
1 likes
The American Society of Gene and Cell Therapy (#ASGCT) 2025 annual meeting is underway! If you're in New Orleans, don't miss your chance to connect with our on-site experts, including Michael Rice buff.ly/PdS2UqP
#ASGCT2025 #GeneAndCellTherapy #CellAndGeneTherapy #CellAndGene #AdvancedTherapeutics
#ASGCT2025 #GeneAndCellTherapy #CellAndGeneTherapy #CellAndGene #AdvancedTherapeutics
May 14, 2025 at 1:52 PM
Everybody can reply
LucidQuest Views >>> Cell and Gene Therapy Weekly News – July 24th 2025 #News #BiotechInnovation #CAR_T #cellandgenetherapy Comment below!
Cell and Gene Therapy Weekly News – July 24th 2025
🧬 This Week in Gene & Cell Therapy: Klotho’s Gene Therapy Deal, Sarepta’s FDA Challenge, NKGen Approval and More From […]
The post Cell and Gene Therapy Weekly News – July 24th 2025 appeared first on LucidQuest Ventures.
dlvr.it
July 24, 2025 at 10:50 AM
Everybody can reply
1 reposts
Cost, location, flexibility: Cell and Gene Therapy Catapult explains why they chose the Maxwell® for their training lab.
Watch the full story on the Promega UK YouTube channel at https://youtu.be/wGyQQyurA5c
#LifeScientists #LabWare #CellAndGeneTherapy
Watch the full story on the Promega UK YouTube channel at https://youtu.be/wGyQQyurA5c
#LifeScientists #LabWare #CellAndGeneTherapy
September 11, 2025 at 8:07 AM
Everybody can reply
1 likes
LucidQuest Views >>> Cell and Gene Therapy Clinical Trials 2025 Edition: Introduction Cell and gene therapy (CGT) represents a groundbreaking frontier in modern medicine, offering innovative treatments for a wide range […]
The post Cell… #Insights #biotech #cellandgenetherapy #CGT Comment below!
The post Cell… #Insights #biotech #cellandgenetherapy #CGT Comment below!
Cell and Gene Therapy Clinical Trials 2025 Edition
Introduction Cell and gene therapy (CGT) represents a groundbreaking frontier in modern medicine, offering innovative treatments for a wide range […]
The post Cell and Gene Therapy Clinical Trials 2025 Edition appeared first on LucidQuest Ventures.
dlvr.it
March 11, 2025 at 3:38 PM
Everybody can reply
FYI: LucidQuest Views >>> Cell and Gene Therapy Clinical Trials 2025 Edition: Introduction Cell and gene therapy (CGT) represents a groundbreaking frontier in modern medicine, offering innovative treatments for a wide range […]
The post… #Insights #biotech #cellandgenetherapy #CGT Comment below!
The post… #Insights #biotech #cellandgenetherapy #CGT Comment below!
Cell and Gene Therapy Clinical Trials 2025 Edition
Introduction Cell and gene therapy (CGT) represents a groundbreaking frontier in modern medicine, offering innovative treatments for a wide range […]
The post Cell and Gene Therapy Clinical Trials 2025 Edition appeared first on LucidQuest Ventures.
dlvr.it
March 19, 2025 at 3:41 PM
Everybody can reply
Connect with me while on-site through the partnering system! I'm looking forward to connecting with industry leaders to tackle the most pressing issues facing #CellAndGeneTherapy. See you in Rome!
April 8, 2025 at 1:17 PM
Everybody can reply
From me yesterday, Tune Tx picks up $175M for #cellandgenetherapy: www.biopharmadive.com/news/tune-se...
Tune raises $175M for hepatitis B medicine, epigenetic research
The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat chronic hepatitis B infections.
www.biopharmadive.com
January 13, 2025 at 5:52 PM
Everybody can reply
@genethonfr.bsky.social r is registered to attend @alliancerm.bsky.social #CGMesa25! Can't wait to dive into discussions, network with industry leaders, and explore the latest advancements in #cellandgenetherapy.
Let the countdown begin!
See you in Phoenix! 🌵
#CGMESA #GeneTherapy #ClinicalTrial
Let the countdown begin!
See you in Phoenix! 🌵
#CGMESA #GeneTherapy #ClinicalTrial
October 3, 2025 at 7:55 AM
Everybody can reply
Heading to #ISCT2025? Let’s talk!
Title21’s integrated software helps #CellAndGeneTherapy teams optimize workflows, improve compliance, and scale treatments faster.
Book a meeting for a custom demo in NOLA! 👉https://share.hsforms.com/2ln_rq9x-RfuwKGnKhEu93A126sl
Title21’s integrated software helps #CellAndGeneTherapy teams optimize workflows, improve compliance, and scale treatments faster.
Book a meeting for a custom demo in NOLA! 👉https://share.hsforms.com/2ln_rq9x-RfuwKGnKhEu93A126sl
April 28, 2025 at 5:30 PM
Everybody can reply
New article provides a fantastic overview of next-gen #InVivo #CARTcellTherapies, delivery systems, mfg process, possible drawbacks, and a future that might include #CARNK and #CARM. #CellandGeneTherapy #CARTcells #CellTherapyManufacturing
translational-medicine.biomedcentral.com/articles/10....
translational-medicine.biomedcentral.com/articles/10....
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy - Journal of Translational Medicine
In the past decades, Chimeric Antigen Receptor (CAR)-T cell therapy has achieved remarkable success, leading to the approval of six therapeutic products for haematological malignancies. Recently, the ...
translational-medicine.biomedcentral.com
January 6, 2025 at 8:31 PM
Everybody can reply
1 likes
Clinics are eager to deliver life-saving #CGT treatments but face challenges—infrastructure gaps, training, and SOP alignment. The solution? Standardization + scalable support.
Watch the full segment: ▶️ themedicinemaker.com/manufacture/...
#CellAndGeneTherapy #BioTherapies #HealthcareInnovation
Watch the full segment: ▶️ themedicinemaker.com/manufacture/...
#CellAndGeneTherapy #BioTherapies #HealthcareInnovation
May 20, 2025 at 5:28 PM
Everybody can reply
How can we bridge academia and industry to advance #CellAndGeneTherapy? 🔬
Last month, @cgtcatapult.bsky.social’s Dan Gibson & @ucl.ac.uk’s Qasim Rafiq explored the challenges & opportunities in scaling advanced manufacturing.
Watch the fireside chat 🔥 loom.ly/g0xTB_o
Last month, @cgtcatapult.bsky.social’s Dan Gibson & @ucl.ac.uk’s Qasim Rafiq explored the challenges & opportunities in scaling advanced manufacturing.
Watch the fireside chat 🔥 loom.ly/g0xTB_o
June 23, 2025 at 9:01 AM
Everybody can reply
1 reposts
Some good news for a change.... www.theguardian.com/science/2025... #cellandgenetherapy #celltherapy
Woman who had pioneering cancer treatment 18 years ago still in remission
Researchers say woman treated for neuroblastoma as a child is longest known survivor after having CAR T-cell therapy
www.theguardian.com
March 3, 2025 at 10:21 AM
Everybody can reply
3 likes
Factor Bioscience Sues Cellectis and AstraZeneca Alleging Infringement of Gene-Editing Patents
#CellandGeneTherapy #BigMoleculeWatch #GeneEditing
www.bigmoleculewatch.com/2025/09/26/f...
#CellandGeneTherapy #BigMoleculeWatch #GeneEditing
www.bigmoleculewatch.com/2025/09/26/f...
Factor Bioscience Sues Cellectis and AstraZeneca Alleging Infringement of Gene-Editing Patents
On September 26, 2025, Factor Bioscience Inc. (“Factor”) filed a complaint against Cellectis Inc., Cellectis SA, AstraZeneca PLC, AstraZeneca Ireland Limited, and AstraZeneca Holdings B.V., alleging i...
www.bigmoleculewatch.com
October 9, 2025 at 3:39 PM
Everybody can reply
1 reposts
Will you be at #ISPOR2025 in Montreal in a few weeks? See who’s attending, what we're presenting, and how to schedule a meeting with our experts at buff.ly/nTaL6FR
#OutcomesResearch #HEOR #HealthEconomics #HTA #RWE #PatientCenteredOutcomes #HCEI #CellandGeneTherapy
#OutcomesResearch #HEOR #HealthEconomics #HTA #RWE #PatientCenteredOutcomes #HCEI #CellandGeneTherapy
April 23, 2025 at 11:10 AM
Everybody can reply
🧬 @cgtcatapult.bsky.social is enabling the #CellAndGeneTherapy industry to adopt AI-powered automation, digital twins, and data integration through its Digital and Automation Testbeds.
🔗 loom.ly/NoSlHVg
🔗 loom.ly/NoSlHVg
August 27, 2025 at 9:19 AM
Everybody can reply
We will be at the #ARM #CellAndGene #MeetingOnTheMesa. Connect with us and gain valuable industry insights. Schedule a time to meet with us on PartneringOne: buff.ly/Olg6VgV or email [email protected].
#CellandGene #StrategyConsulting #CellAndGeneTherapy
#CellandGene #StrategyConsulting #CellAndGeneTherapy
September 5, 2025 at 11:10 AM
Everybody can reply
Check out our Head of CDMO Global Operations Alan Griffith PhD discuss how vectors are the unsung heroes of cell and gene therapy in a new episode of Transformation in Trials!
📽 YouTube: www.youtube.com/watch?v=BgXF...
#cellandgenetherapy #cdmo #gmp #breakthroughtherapy #lifesciences #podcast
📽 YouTube: www.youtube.com/watch?v=BgXF...
#cellandgenetherapy #cdmo #gmp #breakthroughtherapy #lifesciences #podcast
From Lab to Patient: Why Vector Design Makes or Breaks Cell Therapies with Alan Griffith
YouTube video by Transformation in Trials
www.youtube.com
March 26, 2025 at 3:09 PM
Everybody can reply
1 likes
Will you be at the American Society of Gene & Cell Therapy (ASGCT) annual meeting? If so, be sure to connect with our on-site experts, including Michael Rice buff.ly/PdS2UqP
#ASGCT #ASGCT2025 #GeneAndCellTherapy #CellAndGeneTherapy #CellAndGene #AdvancedTherapeutics
#ASGCT #ASGCT2025 #GeneAndCellTherapy #CellAndGeneTherapy #CellAndGene #AdvancedTherapeutics
May 6, 2025 at 1:10 PM
Everybody can reply